Activation of HIF2 leads to vascular remodeling and inflammation, coronary thrombosis and arterial dilation, recapitulating cardiac involvement of Kawasaki disease.
B. Escobar, I. Menendez-Montes, T. Albendea-Gomez, S. Mendoza-Tamajon, R. Castro-Mecinas, C. Diaz-Diaz, B. Palacios, J. Ruiz-Cabello, L. J. Jimenez-Borreguero, M. C. Cid, K. Takahashi, S. Martin-Puig
This study shows that activating HIF2 causes vascular remodeling, inflammation, and coronary issues similar to Kawasaki disease, using a new mouse model and human tissue analysis.
bioRxiv · Jan 22, 2024 · PreprintPathology